Indefinite Delivery Contract SPE2DV17D8268

The federal contract IDV award SPE2DV17D8268 is a single-award Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $4,999,999.00 and an ultimate completion date of June 7, 2027. It was awarded on June 7, 2017 by the Defense Logistics Agency (DLA) to provide a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515. The contract covers items such as surgical dressings, drugs, biologicals, medical consumables, and specialized medical equipment, supporting military treatment facilities and other Department of Defense healthcare providers. As a critical vendor in the federal healthcare supply chain, Cardinal Health 200, LLC leverages its extensive distribution network and expertise to deliver essential medical supplies efficiently to government agencies. The IDC structure allows for the issuance of multiple delivery orders against the master contract, providing government healthcare providers with a flexible and responsive procurement mechanism for their medical product needs.

Cardinal Health, Inc., the parent company of Cardinal Health 200, LLC, also holds significant federal contracts and IDVs, primarily focused on pharmaceutical distribution services. This includes a single-award IDC with the Department of Veterans Affairs (VA) for the provision of radiopharmaceutical products to support medical imaging procedures within the VA healthcare system. Additionally, the company's subsidiary, The Harvard Drug Group, L.L.C., secured a single-award IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets, demonstrating Cardinal Health's ability to manage large-scale, multi-agency pharmaceutical supply agreements.